Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29100374)

  • 1. Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.
    Santagata S; Napolitano M; D'Alterio C; Desicato S; Maro SD; Marinelli L; Fragale A; Buoncervello M; Persico F; Gabriele L; Novellino E; Longo N; Pignata S; Perdonà S; Scala S
    Oncotarget; 2017 Sep; 8(44):77110-77120. PubMed ID: 29100374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment.
    Santagata S; Rea G; Castaldo D; Napolitano M; Capiluongo A; D'Alterio C; Trotta AM; Ieranò C; Portella L; Di Maro S; Tatangelo F; Albino V; Guarino R; Cutolo C; Izzo F; Scala S
    Hepatol Int; 2024 Apr; 18(2):568-581. PubMed ID: 37142825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients.
    Santagata S; Rea G; Bello AM; Capiluongo A; Napolitano M; Desicato S; Fragale A; D'Alterio C; Trotta AM; Ieranò C; Portella L; Persico F; Di Napoli M; Di Maro S; Feroce F; Azzaro R; Gabriele L; Longo N; Pignata S; Perdonà S; Scala S
    Br J Cancer; 2024 Jun; 130(12):2016-2026. PubMed ID: 38704478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation Tolerance.
    Braza F; Dugast E; Panov I; Paul C; Vogt K; Pallier A; Chesneau M; Baron D; Guerif P; Lei H; Laplaud DA; Volk HD; Degauque N; Giral M; Soulillou JP; Sawitzki B; Brouard S
    J Am Soc Nephrol; 2015 Aug; 26(8):1795-805. PubMed ID: 25556168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of apoptosis of CD4+ CD25+ regulatory T cells on proliferation as well as secretion of effector T cells and interventional activity of Xuebijing injection in septic rats].
    Ai YH; Yao YM; Dai XG
    Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(1):58-61. PubMed ID: 19484954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
    Wang ZH; Zhu JY; Li T; Leng XS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
    Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
    Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients.
    Alvarez Salazar EK; Cortés-Hernández A; Alemán-Muench GR; Alberú J; Rodríguez-Aguilera JR; Recillas-Targa F; Chagoya de Sánchez V; Cuevas E; Mancilla-Urrea E; Pérez García M; Mondragón-Ramírez G; Vilatobá M; Bostock I; Hernández-Méndez E; De Rungs D; García-Zepeda EA; Soldevila G
    Front Immunol; 2017; 8():219. PubMed ID: 28316600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal cell carcinoma may evade the immune system by converting CD4+Foxp3- T cells into CD4+CD25+Foxp3+ regulatory T cells: Role of tumor COX-2-derived PGE2.
    Li J; Feng G; Liu J; Rong R; Luo F; Guo L; Zhu T; Wang G; Chu Y
    Mol Med Rep; 2010; 3(6):959-63. PubMed ID: 21472340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients.
    Bouvy AP; Klepper M; Kho MM; Boer K; Betjes MG; Weimar W; Baan CC
    Nephrol Dial Transplant; 2014 Aug; 29(8):1587-97. PubMed ID: 24771499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
    Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
    BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+CD25+CD127(low) Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Sharma S; Khosla R; David P; Rastogi A; Vyas A; Singh D; Bhardwaj A; Sahney A; Maiwall R; Sarin SK; Trehanpati N
    Front Immunol; 2015; 6():49. PubMed ID: 25767469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients.
    Desar IM; Jacobs JH; Hulsbergen-vandeKaa CA; Oyen WJ; Mulders PF; van der Graaf WT; Adema GJ; van Herpen CM; de Vries IJ
    Int J Cancer; 2011 Jul; 129(2):507-12. PubMed ID: 20839259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.
    Yokokawa J; Cereda V; Remondo C; Gulley JL; Arlen PM; Schlom J; Tsang KY
    Clin Cancer Res; 2008 Feb; 14(4):1032-40. PubMed ID: 18281535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
    Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
    Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating regulatory T cells are positively correlated with angiogenic status in renal cell carcinoma.
    Ning H; Shao QQ; Ding KJ; Gao DX; Lu QL; Cao QW; Niu ZH; Fu Q; Zhang CH; Qu X; Lü JJ
    Chin Med J (Engl); 2012 Jun; 125(12):2120-5. PubMed ID: 22884140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.